National Academies Press: OpenBook
« Previous: Appendix A Agenda
Suggested Citation:"Appendix B Acronyms." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
×

Appendix B
Acronyms

ABM agent-based models

ACIP Advisory Committee on Immunization Practices

AIDS Acquired Immunodeficiency Syndrome

APEC Asia-Pacific Economic Cooperation

APHA American Public Health Association

ARV Antiretroviral

ASEAN Association of Southeast Asian Nations

BSE bovine spongiform encephalopathy

CDC Centers for Disease Control and Prevention

CISAC Committee on International Security and Arms Control

CSTE Council of State and Territorial Epidemiologists

DHS U.S. Department of Homeland Security

EPA U.S. Environmental Protection Agency

FAO Food and Agriculture Organization

GEIS Global Emerging Infections System

GOARN Global Outbreak Alert and Response Network

GPHIN Global Public Health Intelligence Network

Suggested Citation:"Appendix B Acronyms." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
×

HHS Department of Health and Human Services

HIV Human Immunodeficiency Virus

HRSA Health Resources and Services Administration

HSC Homeland Security Council

ICU Intensive Care Unit

IHR International Health Regulations

IOM Institute of Medicine

MIDAS Models of Infectious Disease Agent Study

NGO Nongovernmental organization

NIH National Institutes of Health

NIPPP National Influenza Pandemic Preparedness Plans

NPI Nonpharmaceutical Interventions

NSPI National Strategy for Pandemic Influenza

NVAC National Vaccine Advisory Committee

NYAM New York Academy of Medicine

OIE Office International des Epizooties (World Organization for Animal Health)

PAHO Pan-American Health Organization

PATH Program for Appropriate Technology in Health

PPE personal protective equipment

SARS Severe Acute Respiratory Syndrome

SNS Strategic National Stockpile

UN United Nations

UNAIDS United Nations Programme on AIDS

UNESCO United Nations Educational, Scientific, and Cultural Organization

UNICEF United Nations Children’s Fund

USAID U.S. Agency for International Development

WHO World Health Organization

Suggested Citation:"Appendix B Acronyms." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
×
Page207
Suggested Citation:"Appendix B Acronyms." Institute of Medicine. 2007. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11917.
×
Page208
Next: Appendix C Forum Member Biographies »
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary Get This Book
×
Buy Paperback | $72.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

In recent public workshops and working group meetings, the Forum on Microbial Threats of the Institute of Medicine (IOM) has examined a variety of infectious disease outbreaks with pandemic potential, including those caused by influenza (IOM, 2005) and severe acute respiratory syndrome (SARS) (IOM, 2004). Particular attention has been paid to the potential pandemic threat posed by the H5N1 strain of avian influenza, which is now endemic in many Southeast Asian bird populations. Since 2003, the H5N1 subtype of avian influenza has caused 185 confirmed human deaths in 11 countries, including some cases of viral transmission from human to human (WHO, 2007). But as worrisome as these developments are, at least they are caused by known pathogens. The next pandemic could well be caused by the emergence of a microbe that is still unknown, much as happened in the 1980s with the emergence of the human immunodeficiency virus (HIV) and in 2003 with the appearance of the SARS coronavirus.

Previous Forum meetings on pandemic disease have discussed the scientific and logistical challenges associated with pandemic disease recognition, identification, and response. Participants in these earlier meetings also recognized the difficulty of implementing disease control strategies effectively.
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary as a factual summary of what occurred at the workshop.
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!